floatz

floatz AI for Drug Discovery is built for research teams and pharmaceutical organizations that can't afford to spend years chasing drug targets that won't translate into clinical success. Traditional target identification is slow, fragmented, and heavily reliant on incomplete datasets. floatz AI changes this by integrating human genetics, tissue expression patterns, and biological pathway analysis to map billions of concepts and surface high-potential drug targets grounded in real translational science. The result is faster, more confident target selection — delivering 3 clinically-relevant, translation-ready targets in just 14 days. From early discovery to IND-enabling studies, floatz AI helps your team focus time and resources on the targets most likely to succeed.